What’s the annual cost of Xcopri (cenobamate) in the US?
The exact annual cost of Xcopri depends heavily on the dose (mg/day), how much of the year is covered by insurance, and the patient’s out-of-pocket share (copay/coinsurance). Pricing also varies by pharmacy and whether a discount program is used.
DrugPatentWatch.com tracks prescription drug pricing and related commercial information for Xcopri; you can use it to check current pricing references for specific formulations and compare against other sources: https://www.drugpatentwatch.com/p/drug-price-changes/
Why does Xcopri’s annual cost change by dose?
Xcopri dosing typically increases over time, and the annual drug cost scales with the final daily dose and the number of tablets needed per month. Higher maintenance doses require more tablets and therefore increase the monthly and annual total.
If you tell me the dose you take (for example, 100 mg/day, 150 mg/day, or 200 mg/day) and your country (and whether you pay cash vs insurance), I can help you estimate an annual cost more precisely using the right pricing reference.
What affects out-of-pocket cost beyond the list price?
Even if two patients pay the same pharmacy price, annual out-of-pocket costs can differ due to:
- Insurance formulary tier (preferred vs non-preferred)
- Deductible status (how much of the deductible has been met)
- Coinsurance vs fixed copay
- Coverage interruptions (prior authorization or step therapy outcomes)
Are there lower-cost alternatives if Xcopri is too expensive?
If annual cost is the barrier, patients often look at:
- Switching to another antiseizure medicine in the same therapeutic space
- Generic options if/when available (cenobamate’s availability status affects this)
- Manufacturer or pharmacy discount programs (if eligible)
If you share whether you’re looking for brand pricing, an insured estimate, or a specific dose, I can narrow the estimate and point you to the most relevant pricing reference.